Mycophenolate Mofetil

If you find any inaccurate information, please let us know by providing your feedback here

Mycophenolate Mofetil

Ước tính: 1 phút đọc, Ngày đăng:

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition

Issued and maintained by the United States Pharmacopeial Convention (USP)

DOWNLOAD PDF HERE

C23H31NO7           433.49

4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-;2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate

CAS RN: 128794-94-5; UNII: 9242ECW6R0.

1 DEFINITION

Mycophenolate mofetil contains NLT 98.0% and NMT 102.0% of mycophenolate mofetil (C23H31NO7), calculated on the dried basis.

2 IDENTIFICATION

Change to read:

A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K (CN 1-MAY-2020)

B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.

3 ASSAY

PROCEDURE

Buffer: Triethylamine and water (1:325). Adjust with phosphoric acid to a pH of 5.3.

Mobile phase: Acetonitrile and Buffer (7:13)

Standard solution: 0.4 mg/ml of USP Mycophenolate Mofetil RS in acetonitrile

Sample solution: 0.4 mg/mL of Mycophenolate Mofetil in acetonitrile

Chromatographic system

(See Chromatography (621), System Suitability.)

Mode: LC

Detector: UV 250 nm

Column: 4.6-mm x 25-cm; 5-µm packing L7

Column temperature: 45°

Flow rate: 1.5 mL/min

Injection volume: 10 µL

System suitability

Sample: Standard solution

Suitability requirements

Tailing factor: NMT 2.0

Relative standard deviation: NMT 1.0%

Analysis

Samples: Standard solution and Sample solution

Calculate the percentage of mycophenolate mofetil (C23H31NO7) in the portion of Mycophenolate Mofetil taken:

Result = (ru /rs ) × (Cs /Cu ) × 100

ru = peak response from the Sample solution

rs = peak response from the Standard solution

Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)

Cu = concentration of Mycophenolate Mofetil in the Sample solution (mg/mL)

Acceptance criteria: 98.0%–102.0% on the dried basis

4 IMPURITIES

RESIDUE ON IGNITION (281): NMT 0.1%

ORGANIC IMPURITIES

Buffer and Mobile phase: Prepare as directed in the Assay.

Sample solution: 2 mg/mL of Mycophenolate Mofetil in acetonitrile

System suitability solution: 10 µg/mL each of USP Mycophenolate Mofetil Related Compound A RS and USP Mycophenolate Mofetil Related Compound B. RS in acetonitrile

Chromatographic system

(See Chromatography (621), System Suitability.)

Mode: LC

Detector: UV 250 nm

Column: 4.6-mm x 25-cm; 5-µm packing L7

Column temperature: 45°

Flow rate: 1.5 mL/min

Injection volume: 10 µL

System suitability

Sample: System suitability solution

Suitability requirements

Resolution: NLT 1.5 between mycophenolate mofetil related compound A and mycophenolate mofetil related compound B

Analysis

Sample: Sample solution

Calculate the percentage of each impurity in the portion of Mycophenolate Mofetil taken:

Result = (ru /rT ) × 100

ru = peak response for each impurity

rT = sum of all the peak responses

Acceptance criteria: See Table 1. Disregard any peak less than 0.03%.

Table 1

NameRelative Retention TimeAcceptance Criteria, NMT (%)
Mycophenolic acida0.330.50
Mycophenolate mofetil related compound Ab0.450.10
Mycophenolate mofetil related compound Bc 0.490.10
N-Oxide analogd0.600.10
1-Morpholinoethoxy analoge0.860.10
Mycophenolate mofetil1.0-
Z-Mycophenolate mofetilf1.10.10
O-Methyl analogg1.20.10
Methyl mycophenolateh1.50.10
Any single unspecied impurity-0.10
Total impurities-0.70

a (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid.

b 2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

c (RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuran-1-one.

d 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate N-oxide.

e 2-Morpholinoethyl (RS)-(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-1-(2-morpholinoethoxy)-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

f 2-Morpholinoethyl (Z)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

g 2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

h Methyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

5 SPECIFIC TESTS

LOSS ON DRYING (731).

Analysis: Dry a sample under vacuum at 60 for 3 h.

Acceptance criteria: NMT 0.5%

6 ADDITIONAL REQUIREMENTS

PACKAGING AND STORAGE: Preserve in tight containers, and store at room temperature.

USP REFERENCE STANDARDS (11)

USP Mycophenolate Mofetil RS

USP Mycophenolate Mofetil Related Compound A RS

2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.

C22H29NO7             419.47

USP Mycophenolate Mofetil Related Compound B RS

(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuran-1-one.

C17H20O6               320.34

vui lòng chờ tin đang tải lên

Vui lòng đợi xử lý......

0 SẢN PHẨM
ĐANG MUA
hotline
0927.42.6789